Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.
复制标题
SIRT6上调可预测不良预后并通过ERK1/2/MMP9通路促进非小细胞肺癌转移
DOI:
10.18632/oncotarget.9750
复制
发表时间:
2016-06-28
期刊:
影响因子:
--
通讯作者:
Xie C
中科院分区:
文献类型:
--
作者:
Bai L;Lin G;Sun L;Liu Y;Huang X;Cao C;Guo Y;Xie C
Sirtuin6 (SIRT6), a member of the sirtuins protein family, plays multiple complex roles in cancer. Here, we report that elevated SIRT6 expression was correlated with clinicopathological parameters such as T and N classification in non-small cell lung cancer (NSCLC) patient tumors. SIRT6 overexpression in NSCLC cell lines increased extracellular signal-regulated kinase (p-ERK)1/2 phosphorylation, activated matrix metalloproteinase 9 (MMP9) and promoted tumor cell migration and invasion. Upon treatment with a specific mitogen-activated protein kinase (MEK) 1/2 inhibitor, these effects were abolished. Our results demonstrate SIRT6 upregulation in NSCLC for the first time and suggest a functional role for SIRT6 in promoting migration and invasion through ERK1/2/MMP9 signaling. SIRT6 may serve as a potential therapeutic target in NSCLC and its utility as a prognostic indicator warrants further study.
登录
查看更多内容
影响因子:
4.6
作者:
Fu Lin;Xie Chengyao;Wang Yan
通讯作者:
Wang Yan
影响因子:
4.8
作者:
Liszt, G;Ford, E;Guarente, L
通讯作者:
Guarente, L
影响因子:
9.6
作者:
Detterbeck, Frank C.;Boffa, Daniel J.;Tanoue, Lynn T.
通讯作者:
Tanoue, Lynn T.
DOI:
10.1097/jto.0000000000000066
发表时间:
2014-02
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
Lin G;Sun L;Wang R;Guo Y;Xie C
通讯作者:
Xie C
影响因子:
--
作者:
Kim HC;Kim YS;Oh HW;Kim K;Oh SS;Kim JT;Kim BY;Lee SJ;Choe YK;Kim DH;Kim SH;Chae SW;Kim KD;Lee HG
通讯作者:
Lee HG